Patent Court gives decision in favor of Layla generics, nullifying its composition patent

The composition patent of ‘Layla(PMG Pharm),’ a natural drug for osteoarthritis making approximately KRW 20 billion sales, received a decision of nullification at the Patent Court.

Mother’s Pharm led the nullification of its composition patent only in a half year at the Patent Court after the Intellectual Property Tribunal’s decision of nullification last year while its use patent has already ...